For IL-1β and TNF-α, there were significant differences between CAD patients and controls in participants of hypertension (p < 0.001 and p < 0.001), diabetes (p = 0.017 and p = 0.025), respectively. This evidence concerns the gene TNF and coronary artery disorder.